[1]
“Are tyrosine kinase inhibitors promising for the treatment of systemic sclerosis and other fibrotic diseases?”, Swiss Med Wkly, vol. 140, no. 1516, pp. 1–7, Apr. 2010, doi: 10.4414/smw.2010.12721.